California State Teachers Retirement System Regeneron Pharmaceuticals, Inc. Transaction History

California State Teachers Retirement System

$78.1 Billion
Q1 2024

A detailed history of California State Teachers Retirement System transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 173,049 shares of REGN stock, worth $181 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

173,049

Previous 171,401 0.96%

Holding current value

$181 Million

Previous $151 Million 10.64%

% of portfolio

0.21%

Previous 0.21%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $1.49 Million - $1.64 Million	1,648 Added 0.96%	173,049 $167 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $512,393 - $582,803	661 Added 0.39%	171,401 $151 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $4.03 Million - $4.91 Million	-5,820 Reduced 3.3%	170,740 $141 Million
Q2 2023 Aug 21, 2023	SELL	$700.03 - $830.35 $2.21 Million - $2.62 Million	-3,159 Reduced 1.76%	176,560 $127 Million
Q1 2023 May 09, 2023	SELL	$680.49 - $826.97 $1.25 Million - $1.51 Million	-1,830 Reduced 1.01%	179,719 $148 Million

Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $1.19 Million - $1.29 Million	1,679 Added 0.93%	181,549 $131 Million
Q3 2022 Nov 18, 2022	SELL	$573.97 - $724.32 $143,492 - $181,080	-250 Reduced 0.14%	179,870 $124 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $1.57 Million - $2.12 Million	2,863 Added 1.62%	180,120 $106 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $5.08 Million - $5.96 Million	-8,530 Reduced 4.59%	177,257 $124 Million
Q4 2021 Feb 15, 2022	BUY	$543.48 - $670.97 $4.64 Million - $5.73 Million	8,546 Added 4.82%	185,787 $117 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $559,679 - $663,936	975 Added 0.55%	177,241 $107 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $4.65 Million - $5.49 Million	-9,837 Reduced 5.29%	176,266 $98.5 Million
Q1 2021 May 18, 2021	BUY	$446.73 - $548.2 $487,382 - $598,086	1,091 Added 0.59%	186,103 $88.1 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $2.12 Million - $2.69 Million	4,431 Added 2.45%	185,012 $89.4 Million
Q3 2020 Nov 17, 2020	BUY	$544.75 - $658.21 $2.95 Million - $3.56 Million	5,411 Added 3.09%	180,581 $101 Million
Q2 2020 Aug 17, 2020	BUY	$493.32 - $643.92 $14.5 Million - $19 Million	29,452 Added 20.21%	175,170 $109 Million
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $171,115 - $251,664	-509 Reduced 0.35%	145,718 $71.2 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $2.9 Million - $3.98 Million	10,572 Added 7.79%	146,227 $54.9 Million
Q3 2019 Nov 15, 2019	BUY	$273.46 - $318.39 $266,896 - $310,748	976 Added 0.72%	135,655 $37.6 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $674,399 - $933,759	2,251 Added 1.7%	134,679 $42.2 Million
Q1 2019 May 09, 2019	BUY	$372.08 - $439.57 $865,830 - $1.02 Million	2,327 Added 1.79%	132,428 $54.4 Million
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $888,915 - $1.07 Million	2,647 Added 2.08%	130,101 $48.6 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $2,106 - $2,451	6 Added 0.0%	127,454 $51.5 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $383,071 - $464,356	1,346 Added 1.07%	127,448 $44 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $1.36 Million - $1.69 Million	-4,303 Reduced 3.3%	126,102 $43.4 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $275,427 - $360,921	-768 Reduced 0.59%	130,405 $49 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $56.6 Million - $66.1 Million	131,173	131,173 $58.7 Million

Others Institutions Holding REGN

# of Institutions

1,426

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account

California State Teachers Retirement System Regeneron Pharmaceuticals, Inc. Transaction History